Correlation Between GM and OncoVista Innovative

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GM and OncoVista Innovative at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GM and OncoVista Innovative into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Motors and OncoVista Innovative Therapies, you can compare the effects of market volatilities on GM and OncoVista Innovative and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short position of OncoVista Innovative. Check out your portfolio center. Please also check ongoing floating volatility patterns of GM and OncoVista Innovative.

Diversification Opportunities for GM and OncoVista Innovative

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GM and OncoVista is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding General Motors and OncoVista Innovative Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoVista Innovative and GM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Motors are associated (or correlated) with OncoVista Innovative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoVista Innovative has no effect on the direction of GM i.e., GM and OncoVista Innovative go up and down completely randomly.

Pair Corralation between GM and OncoVista Innovative

Allowing for the 90-day total investment horizon GM is expected to generate 3.07 times less return on investment than OncoVista Innovative. But when comparing it to its historical volatility, General Motors is 4.14 times less risky than OncoVista Innovative. It trades about 0.05 of its potential returns per unit of risk. OncoVista Innovative Therapies is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  0.01  in OncoVista Innovative Therapies on September 3, 2024 and sell it today you would earn a total of  0.00  from holding OncoVista Innovative Therapies or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

General Motors  vs.  OncoVista Innovative Therapies

 Performance 
       Timeline  
General Motors 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in General Motors are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very weak primary indicators, GM displayed solid returns over the last few months and may actually be approaching a breakup point.
OncoVista Innovative 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OncoVista Innovative Therapies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable forward indicators, OncoVista Innovative is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

GM and OncoVista Innovative Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GM and OncoVista Innovative

The main advantage of trading using opposite GM and OncoVista Innovative positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GM position performs unexpectedly, OncoVista Innovative can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoVista Innovative will offset losses from the drop in OncoVista Innovative's long position.
The idea behind General Motors and OncoVista Innovative Therapies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing